반응식
[Cl:1][C:2]1[N:3]=[CH:4][C:5]2[NH:11][C:10](=[O:12])[CH2:9][CH2:8][N:7]([CH2:13][CH2:14][O:15][CH3:16])[C:6]=2[N:17]=1.[CH3:18]N(C)C(=O)C.IC.[H-].[Na+]>O>[Cl:1][C:2]1[N:3]=[CH:4][C:5]2[N:11]([CH3:18])[C:10](=[O:12])[CH2:9][CH2:8][N:7]([CH2:13][CH2:14][O:15][CH3:16])[C:6]=2[N:17]=1참가 물질
6
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
To a mixture of 0.102 g (0.0004 mole) of 2-chloro-9-(2-methoxy-ethyl)-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VI-40), 1 mL of N,N-dimethylacetamide and 0.037 mL (0.0006 mole) of iodomethane at 0 degrees was added 0.024 g (0.0006 mole) of 60% sodium hydride in oil. The mixture was stirred at ambient temperature for 1 hour, then 20 mL of water was added. The precipitate was collected by filtration to give 0.087 g of 2-chloro-9-(2-methoxy-ethyl)-5-methyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VII-40) as an yellow solid.
후처리
- filtrationThe precipitate was collected by filtration
출처 및 근거
- ORD 기록
- ord-fb21e6ee0f4c47858efc14e494bffa5b
- 출처 데이터셋
- uspto-grants-2009_04
- 특허 번호
- US07517873B2
연결된 노트
불러오는 중…